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Abstract
Background:  A review of the safety and efficacy of drinking water fluoridation was commissioned
by the UK Department of Health to investigate whether the evidence supported a beneficial effect
of water fluoridation and whether there was any evidence of adverse effects. Down's syndrome
was one of the adverse effects reported. The aim of this review is to examine the evidence for an
association between water fluoride level and Down's syndrome.
Methods:  A systematic review of research. Studies were identified through a comprehensive
literature search, scanning citations and online requests for papers. Studies in all languages which
investigated the incidence of Down's syndrome in areas with different levels of fluoride in their
water supplies were included. Study inclusion and quality was assessed independently by 2
reviewers. A qualitative analysis was conducted.
Results:  Six studies were included. All were ecological in design and scored poorly on the validity
assessment. The estimates of the crude relative risk ranged from 0.84 to 3.0. Four studies showed
no significant associations between the incidence of Down's syndrome and water fluoride level and
two studies by the same author found a significant (p < 0.05) positive association (increased Down's
syndrome incidence with increased water fluoride level). Only two of the studies controlled for
confounding factors and only one of these presented summary outcome measures.
Conclusions:  The evidence of an association between water fluoride level and Down's syndrome
incidence is inconclusive.
Introduction
A review of the safety and efficacy of drinking water
fluoridation [1]  [http://www.york.ac.uk/inst/crd/fluor-
id.htm]  was commissioned by the UK Department of
Health to investigate whether the evidence supported a
beneficial effect of water fluoridation and whether there
was any evidence of adverse effects. Other than dental
fluorosis, bone fracture and cancer there was very little
evidence available on adverse effects in humans. Down's
syndrome was the most discussed of the other adverse
effects reported and was therefore selected as the focus
for this paper.
In approximately 90% of cases, Down's syndrome is due
to the non-disjunction of chromosome 21, most often in
the oocyte, which may occur during two separate peri-
ods: before the completion of the first meiosis or around
the time of ovulation.[2] Exposure to risk factors should
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therefore be measured at the time at which the abnor-
mality may occur, around the time of conception. The
main risk factor for Down's syndrome is maternal age
with many studies having shown an increased incidence
of Down's syndrome with increased maternal age.[3]
There has also been some suggestion of an association
with paternal age however this has not been confirmed.
[4] Other suggested risk factors include race, with an in-
crease rate among Hispanic mothers, [5,6] ionising radi-
ation, [2, 7] increased parity, [3, 8] although this has not
been confirmed by all studies, [9] and season, with a
peak in births in summer. [10] Any study of a risk factor
for Down's syndrome, such as water fluoride level,
should consider these other suggested risk factors as
possible confounding factors, and should certainly make
attempts to control for the confounding effects of mater-
nal age.
Water fluoride level has been suggested as a possible risk
factor for Down's syndrome and its association with wa-
ter fluoride exposure has been investigated by a number
of studies. If fluoride is associated with Down's syn-
drome then other sources of fluoride may act to con-
found the association of water fluoride level with the
incidence of Down's syndrome. For example, two women
living in different areas, one with a high water fluoride
level and the other with a low water fluoride level, might
be receiving similar amounts of fluoride if the woman in
the low fluoride area was consuming fluoride from other
sources, such as fluoride tablets, tea and fluoridated
toothpaste. Exposure to other sources of fluoride should
thus be considered and measured so that the effects can
be controlled for in the investigation of the association of
Down's syndrome with water fluoride levels.
The objective of this report is to investigate the associa-
tion of water fluoride level with Down's syndrome and
discuss in detail the quality of the studies investigating
this association.
Methods
Search strategy
25 specialist databases were searched by a qualified li-
brarian, including Medline, Embase, Toxline and the
Current Contents (Science Citation Index) from database
inception to February 2000. In addition, hand searching
of Index Medicus (1945–1959) and Excerpta Medica
(1955–1973) was undertaken. Additional references
were sought from individuals and organisations through
a dedicated web site for this review  [http://
www.york.ac.uk/inst/crd/fluoride.htm]  and through
members of a specifically designated advisory panel.
Published and unpublished studies in any language were
included. Full details of the search strategy are reported
elsewhere. [11]
Inclusion criteria
All study designs which compared the incidence of
Down's syndrome in populations with different levels of
fluoride, either artificially added or naturally occurring,
in their water supplies were included in this review.
Data extraction and quality assessment
Two reviewers independently assessed each paper for in-
clusion, disagreements were resolved through consen-
sus. Extraction of data from individual included studies
was independently performed by two reviewers, and
Table 1: Validity criteria used to score studies
Prospective Was the study prospective? Was it 
planned and started prior to the out-
come of interest occurring? 
Score = 1 or 0
Study Design The study design hierarchy for this re-
view = cohort > before-after > ecologi-
cal > cross-sectional. Scores ranged 
from 0.25–1, with cohort = 1, 
cross-sectional = 0.25
Fluoride Measurement Was the Fluoride level reliably meas-
ured? Scores range between 0–1.
Confounding Factors Were confounding factors addressed 
(measured)? Scores range between 0–1, 
with 3 or more factors measured = 1.
Control for 
Confounding
Was there adjustment for the possible 
effect of confounding factors in the anal-
ysis or study design? Scores range be-
tween 0–1, with stratification by age and 
sex = 0.5, other types of analysis 
(e.g. regression) = 1.
Blinding Were those measuring outcomes and 
exposures blind to the exposure/ 
outcome status of the person being 
assessed? Score = 0 or 1
Baseline Survey Was there a baseline survey at the point 
of initiation or discontinuation of water 
fluoridation? Score = 0 or 1
Follow-Up Was the study conducted an adequate 
time after the initiation or discontinua-
tion of water fluoridation to assess 
effects (5 years)? Score = 0 or 1BMC Public Health (2001) 1:6 http://www.biomedcentral.com/1471-2458/1/6
checked by a third reviewer. Disagreements were re-
solved through consensus.
Study validity was formally assessed using a published
checklist modified for this review. [12] The criteria used
to assess study validity were developed for the main
fluoridation review. [1]  [http://www.york.ac.uk/inst/
crd/fluorid.htm]  and were used for all studies included
in the main fluoridation review to allow a general com-
parison between the quality of all of these studies. These
criteria were retained for this paper to allow the results
of the studies which looked at Down's syndrome to be
viewed in the wider context of all studies that looked at
adverse effects of fluoridation, when this paper is consid-
ered together with the full fluoridation review. Each
study was assigned a score, based on the number of
checks achieved on the checklist, out of a maximum
score of eight. The criteria used to score the studies are
described in Table 1. Study validity was assessed inde-
pendently by two reviewers, with disagreements re-
solved through consensus.
Analysis
The studies did not provide sufficient information to per-
mit pooling of data or investigation of statistical hetero-
geneity. A narrative synthesis is presented. For studies
which did not report on crude or adjusted summary
measures such as the risk difference or relative risk but
provided sufficient information to calculate this, a crude
relative risk was calculated with 95% confidence inter-
vals where possible. Where a study looked at more than
2 study areas the area with the lowest fluoride concentra-
tion was compared to the area with a fluoride level clos-
est to 1 ppm. However, results for all study areas are
presented in table 2. Insufficient data was available to in-
vestigate publication bias using standard methods (fun-
nel plots).
Table 2: Individual study details and results
Study Details Outcome and exposure 
details
Inclusion/Exclusion 
Criteria
Group Water 
fluoride 
level 
(parts per 
million)
Number 
of live 
births*
Results 
(crude risk) 
per 100 000*
Author (year) Method of outcome Inclusion criteria Group 1: 0.7–1.1 20760 159.0
Berry (1958) assessment: Children born in study Group 2: 1.9–2.0 14710 122.4
Region of study Institutions, death areas during study Group 3: 0.9 9492 137.0
Essex, England certificates, records of period, mothers living Group 4: <0.2 12620 190.2
Year study started medical officers of in study area at time of Group 5: <0.2 11587 164.0
1945 health authorities, birth Group 6: 0.2 22452 164.8
Study Length personal knowledge of Group 7: 0.2 14873 107.6
9 years health visitors Control: 0.2 6870 131.0
Author (year) Method of outcome Inclusion criteria Metropolitan
Erickson(1976) assessment: Birth of white children area
Region of study Cases identified through only, areas in which Group 1: High 95254 99
Georgia, USA surveillance mothers' usual place Group 2: Low 25373 85
Year study started programmes, data was of residence at birth of NIS p>0.05
1960–1973 supplemented by a child permitted surveillance
Study Length retrospective determination of areas
13 years ascertainment (using exposure to fluoridated Group 1: 234300 49
multiple sources) of water Group 2: 1032100 51
children born between p>0.05
1960 and 1967.
Author (year) Method of outcome Inclusion criteria
Erickson(1980) assessment: Cities with 1970
Region of study Data from birth populations >= 250
USA certificates obtained 000, Cities fluoridated Group 1: >= 0.7 432580 41.1
Year study started from US Nation Center for >= 5 years by 1973 Group 2: 0.7 204185 44.1
1973 for Health Statistics, Exclusion criteria
Study Length denominator number of Cities with mixed Indirect age
2 years live births in study areas fluoridation status standardisedBMC Public Health (2001) 1:6 http://www.biomedcentral.com/1471-2458/1/6
Results
Six studies investigating the association of Down's syn-
drome with water fluoride level were identified [3, 14, 15,
16, 17, 18] these were all ecological in study design. The
studies ranged in publication date from 1957 to 1980,
five were conducted in the USA [14, 15, 16, 17, 18] and
one was conducted in England. [13] Two of the studies
were published in French [17, 16] the others were pub-
lished in English. Study duration ranged from 2 to 17
years. Case ascertainment was from a variety of sources
including birth and death certificates, institutions, sur-
veillance programmes, hospitals, nurseries and schools
for mentally retarded children. Most studies attempted
to measure incidence by identifying all cases born during
States which do not rates:
report birth defects on 41.0
birth certificates 44.0
Cities fluoridated for
<5 years by 1973
Author (year) Method of outcome Inclusion criteria Group 1: 1 81017 153.1
Needleman(1974) assessment: Children born with Group 2: 0.3 1752435 133.8
Region of study Cases identified through Down's's syndrome
Massachusetts, USA maternity and paediatric
Year study started hospitals, Departments
1950 of Public and Mental
Study Length Health, private nurseries
17 years and school for mentally
retarded children,
karyotyping laboratories
and several
miscellaneous sources
Author (year) Method of outcome Inclusion criteria Group 1: 1.0–2.6 67053 71.6
Rapaport (1963) assessment: All cases children with Group 2: 0.3–0.7 70111 47.1
Region of study Cases identified from Down's's syndrome Group 3: 0.1–0.2 132665 39.2
Illinois, USA birth and death born during study Group 4 0.0 63521 23.6
Year study started certificates, registers of period
1950 specialist medical Town (of mother's
Study Length educational state residence) size 10 000
6 years institutions -100 000
Author (year) Method of outcome Inclusion criteria Dakota
Rapaport (1957) assessment: Not stated Group 1: >3 31575 34.8
Region of study Alive subjects with Exclusion criteria Group 2: <3 467685 15.2
USA Down's's syndrome Not stated Illinois
Year study started identified through Group 1: 1.6–2.6 41618 14.4
Not stated institutions (cases living Group 2: 1.0–1.2 210628 11.4
Study Length in the community not Group 3: 0.4–0.7 196258 12.2
Not stated identified) Group 4 0.3 151167 6.6
Group 5: 0.1–0.2 670120 6.0
Group 6: 0.0 7049 3.9
Wisconsin
Group 1: 2.8 52735 30.3
Group 2: 1.4 21538 32.5
Group 3: 0.5 51189 25.4
Group 4 0.1 1076876 13.5
* Rapaport (1957) did not report the total number of births, for this study the population figures are provided and the crude risk is the risk per 100 
000 population
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the study period, [13, 14, 15, 17, 18] however, one study
only measured prevalence, by identifying cases living in
institutions and hospitals. [16] The denominator used to
calculate risks in most studies [13, 14, 15, 17, 18] was the
number of live births in the study areas during the study
period however, one study used the populations of the
study areas as the denominator. [16] Exposure was clas-
sified according to the area of maternal residence for all
but one of the studies [15] which classified exposure ac-
cording to the town of maternal residence 9 months prior
to the birth. None of the studies stated how the areas se-
lected for the study were chosen, although for one study
[15] the data were originally assembled for a large scale
epidemiologic study of Down's syndrome, and data
which could be related to water fluoride exposure were
included for this study. Details of baseline information
and results from each study are presented in table 2.
The quality of these studies was generally poor; the aver-
age validity checklist score was 2.3 with a range of 1.8 to
3.5 out of a possible score of 8. None of the studies had a
prospective follow-up, incorporated any form of blind-
ing, had a baseline survey or stated how the level of fluo-
ride in the water was calculated. Controlling for
confounding factors was generally inadequate. All stud-
ies scored marks for study design (1/2 for using an eco-
logical design) and for adequate length of follow-up i.e.
the survey was carried out more than 5 years after the
water supply had been fluoridated (Table 3).
Table 4 shows the association of water fluoride level and
the incidence of Down's syndrome, together with validity
score and the confounding factors discussed and control-
led for in each study.
Table 3: Validity Assessment (Score out of 8)
Author Prospective Study 
Design
Fluoride 
Measure-
ments
Confounding 
Factors
Control for 
Confounding
Blinding Base-
line 
Survey
Follow-
Up
Score
Erickson (1976) 0 1/2 0 1 1 0 0 1 3.5
Erickson (1980) 0 1/2 0 1 1 0 0 1 3.5
Needleman (1974) 0 1/2 0 1/4 0 0 0 1 1.8
Rapaport (1963) 0 1/2 0 1/4 0 0 0 1 1.8
Rapaport (1957) 0 1/2 0 1/4 0 0 0 1 1.8
Berry (1958) 0 1/2 0 0 0 0 0 1 1.5
Table 4: Association of Down's syndrome with water fluoride level
Author (Year) Crude relative risk Confounding factors 
discussed
in study
Controlled for Validity score
Erickson(1976) 1.16(p > 0.05) Maternal age, race Yes 3.5
0.96 (p > 0.05)
Erickson(1980) 0.93 (0.7, 1.2) Maternal age, race Yes 3.5
Needleman(1974) 1.14 Maternal age No 2.0
Rapaport (1957) 2.3 (p < 0.01) Maternal age No 2.0
2.9 (p < 0.01)
2.4 (p < 0.05)
Rapaport (1963) 3.0(p < 0.001) Maternal age,
minerals in water
No 2.0
Berry (1958) 0.84–1.48 None No 1.8BMC Public Health (2001) 1:6 http://www.biomedcentral.com/1471-2458/1/6
Four of the six studies provided a measure of the signifi-
cance of the association of water fluoride level with
Down's syndrome.[18, 14, 17, 16] Two of these studies
found no significant difference in Down's syndrome inci-
dence between high and lower water fluoride areas. [18,
14] The other two studies, by the same author, found an
increased incidence of Down's syndrome in areas with
higher water fluoride levels (p < 0.01, RR ranged from
2.3 to 3.0).[16, 17] One of the other studies did not find
any association between water fluoride level and Down's
syndrome incidence, [13] depending on the control area
selected, the crude relative risk ranged from 0.84 to 1.48.
The remaining study [15] suggested a positive associa-
tion between water fluoride level and Down's syndrome
incidence (increased incidence with increased water flu-
oride concentration) when only the crude incidence rates
were compared. To achieve some control for maternal
age the analysis was limited to the 30 towns that initiated
fluoridation. The rate of Down's syndrome among births
in fluoridated areas was compared to the combined rate
among births occurring before fluoridation and, for
towns that stopped fluoridation, after fluoridation. Lim-
iting the analysis in this way produced two groups com-
parable in maternal age, and produced similar estimates
of the incidence of Down's syndrome in the two groups.
Another factor thought to be confounding the associa-
tion of Down's syndrome with water fluoride exposure
was time. Time trend was controlled for and produced a
maximum likelihood estimate for the relative risk was
0.95 (95% CI: 0.8, 1.2), suggesting no significant associ-
ation between Down's syndrome and water fluoride lev-
el.
Although all but one study [13] mentioned maternal age
as a confounding factor only two studies controlled for
this in the analysis. [14, 18] Both studies included white
births only and presented results separately for 5 year
age groups. One study [14] also presents age-adjusted
rates. A negative non-significant association of water flu-
oride level with Down's syndrome (decreased incidence
with increased water fluoride concentration) was found
by this study, when controlling for the effects of maternal
age. The other study [18] shows no overall significant dif-
ferences between the study areas for the results stratified
on maternal age, although this study does suggest an in-
creased incidence of Down's syndrome at young mater-
nal ages and a decreased incidence at older ages in the
fluoridated areas. A third study [15] presented the mean
maternal age in the two study areas and stated that the
mean age of mothers was higher in the high fluoride are-
as than the low fluoride areas (34.0 versus 33.2) and sug-
gested that this difference was large enough to account
for the observed difference in Down's syndrome inci-
dence between the two areas, when crude rates were
compared. Another study [17] showed that the propor-
tion of cases among mothers aged over 40 was less (11%)
in high fluoride areas than low fluoride areas (24%). A
study by the same author [16] reported that maternal age
was higher in low fluoride areas (34.3) compared to areas
fluoridated at 1 ppm (33.2), although the groupings of ar-
eas by water fluoride level differ for the description of
maternal age compared to the groupings for Down's syn-
drome incidence.
Discussion
This systematic review suggests that the evidence for an
association between water fluoride level and the inci-
dence of Down's syndrome is weak, and that all the iden-
tified studies were of poor quality. All results, positive
and non-positive, should therefore be considered togeth-
er with the methodological weaknesses of the studies
which could have lead to spurious results. In particular,
the results of the two studies [16, 17] which showed a sig-
nificant positive association with water fluoride level
should be interpreted with extreme caution due to the
methodological limitations of these studies discussed be-
low.
The major weakness of these studies was the failure to
control sufficiently for confounding factors. All six stud-
ies used study designs that measured population rather
than individual exposure to fluoridated water and be-
cause of this are particularly susceptible to confounding.
If the populations being studied differed in respect to
other factors that are associated with the outcome under
investigation then the outcome may differ between these
populations leading to an apparent association with wa-
ter fluoride level. [19] The incidence of Down's syndrome
is known to be strongly associated with maternal age.
[20] If the average maternal age of the high fluoride pop-
ulation is higher than that of the low fluoride population
an association with water fluoride level would most likely
be found, even if such an association does not in fact ex-
ist. Maternal age was considered by all but one of the in-
cluded studies, however only two of the six studies
appropriately controlled for the effects of maternal age.
The two studies [16, 17] which found a positive associa-
tion between Down's syndrome and water fluoride level
were two of the studies which did not control appropri-
ately for the possible confounding effects of maternal age
and so the results of these studies should be interpreted
with some degree of caution. Another factor which may
affect the association of Down's syndrome with water flu-
oride level is maternal exposure to other sources of fluo-
ride, such as fluoridated toothpaste, mouthwashes and
fluoride tablets. None of the studies controlled for or
measured any of these factors.
Other factors which could have led to misleading study
results include selection of study areas, ascertainment ofBMC Public Health (2001) 1:6 http://www.biomedcentral.com/1471-2458/1/6
cases, population selected for the denominator, migra-
tion, classification of exposure and blinding of investiga-
tors to the fluoridation status of cases. If study areas are
not selected at random there is a possibility that selection
may be biased, for example, a fluoridated area with a rel-
atively high incidence of Down's syndrome (possibly for
reasons other than fluoride concentration of the water)
and a non-fluoridated area with a relative low incidence
may be selected which would result in biased results.
Case ascertainment must be as complete as possible and
must be uniform across study areas otherwise cases in
one area may be more likely to be identified than those in
another area and possibly result in a misleading finding.
All but one [16] of the studies attempted to locate all cas-
es born in the study areas during the study period by
searching a variety of sources, these studies all state that
they believe that they located the majority of cases. The
other study [16] limited case ascertainment to live cases
living in institutions and hospitals. Limiting the cases in
this way may result in a large proportion of cases (more
than half) being missed. [14] This would be a particular
problem if the proportion of cases identified differed be-
tween the different areas, for example if a higher propor-
tion of cases lived in institution in the fluoridated area
compared to the control area this would result in a mis-
leading association. Also, if there more deaths among
people with Down's syndrome in one area than another
this could result in fewer living people with Down's syn-
drome in one of the study areas, leading to a possibly bi-
ased association.
The population selected for the denominator may also
affect the associations found. One of the two studies [16]
which found a positive association used the total popula-
tion of the study areas as the denominator while all the
other studies [13, 14, 15, 17, 18] used the number of live
births as the denominator. For studies of birth defects it
is more usual to use the total number of births as the de-
nominator. If the population structure of two areas dif-
fer, with one area having a higher proportion of women
of childbearing age, then the birth rate in this area will
also be higher and thus the incidence of birth defects,
such as Down's syndrome, is likely to be higher. Using
this figure as the denominator can thus lead to false con-
clusions.
Classification of exposure is another area where bias can
be introduced. Down's syndrome is a genetic defect that
occurs at around the time of conception [2] and so water
fluoride exposure should be classified according to the
area in which the mother was resident at the time of con-
ception. Only one study classified exposure at the time of
conception, [15] the others classified exposure at the
time of birth, this may lead to the misclassification of
births to mothers who moved during their pregnancy.
The length of exposure to fluoride necessary to have an
effect could be several years in which case the exposure
should be classified as women exposed or not exposed to
water fluoride for a certain number of years prior to con-
ception. Exposure was not classified in this way in any of
the included studies.
The effects of migration were not discussed in any of the
studies. Whether migration could bias study results de-
pends on when the water fluoride level is thought to have
an effect on the woman: whether it is a long term build
up or a short term effect around the time of conception.
If it is the latter then as long as exposure status was iden-
tified as exposure at time of conception not birth this
should not a problem. However, if there is a fluoride ef-
fect with a long induction period, any study of this effect
would have to take account of migration.
Investigators should be blinded to the fluoridation status
of the cases that they are identifying otherwise their
views on fluoridation may affect the thoroughness of
their search for cases. For example, if an investigator be-
lieves that there is an association between water fluoride
level and down's syndrome, and knows that the sources
they are searching to identify cases relate to cases whose
mothers have been exposed to high levels of water fluo-
ride, they may be more thorough in their search for cas-
es. None of the studies mentioned blinding of
investigators.
The studies included in the review were all conducted at
least 20 years ago. This may be a problem in generalising
results to the present time if factors that would affect the
incidence of Down's syndrome, and especially its associ-
ation with water fluoride levels, have changed in that
time. It may be that if fluoride has an effect on the inci-
dence of Down's syndrome the mother has to be exposed
to fluoride over a long period of time. Fluoridation was
first initiated in the 1940s [21] thus many of the women
included in these studies may only have been exposed to
water fluoride for a short period of time. Another factor
which has changed since most of these studies were con-
ducted is the total fluoride exposure of the mothers, flu-
oride is now available from other sources, to which
women would not have been exposed in the earlier stud-
ies. Other factors which may affect the incidence of
Down's syndrome is the changing demographics of ma-
ternal age at birth, with women in the developed world
now giving birth at older ages than they did 20 years ago.
[22] Abortion is now more acceptable [23] and screening
for Down's syndrome is routine, especially in older wom-
en, [24] and so the option to terminate a birth if the child
is diagnosed with Down's syndrome is now a possibility.BMC Public Health (2001) 1:6 http://www.biomedcentral.com/1471-2458/1/6
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Conclusions
The evidence of an association between water fluoride
level and Down's syndrome incidence is inconclusive.
However, the quality of the studies included in the re-
view was relatively low and further high quality research
is needed. Future studies investigating the association of
Down's syndrome with water fluoride levels should
measure individual exposure to water fluoride and con-
trol appropriately for confounding factors, especially
maternal age, incidence of termination of pregnancies in
which the child is diagnosed with Down's syndrome, and
exposure to other sources of fluoride. Study areas should
be chosen at random and investigators should be blinded
to the fluoridation status of mothers when identifying
cases. The denominator selected to measure the risk of a
Down's syndrome birth should relate to the total number
of births, not to the overall population of the study area.
Case ascertainment should be as complete as possible,
and should be identical in all populations studies.
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